Since the early 2000s next-generation sequencing (NGS Assays) has become an invaluable tool in both drug discovery research and clinical/diagnostic settings.

Pregnancy ultrasounds are well known. Did you know that its first practical use was for detection of objects, propelled by the sinking of the Titanic in 1912?

Pediatric medical devices are critical for proper medical care of children. The connection between innovation and realization is a challenging one.

Clinical literature reviews are critical components to achieving MDR compliance. Review of scientific literature may be needed for many EU MDR deliverables.

1930 methods for scientific research application spearheads AI/ML pattern recognition predictive modeling in in vitro diagnostics 80 years later.

This article explores AI and the some of the potential applications, implications and costs for unprepared industry.

In the wake of the COVID-19 pandemic, the world continues to recover from disruptions in supply chain. Regardless of industry, companies have had to react in a timely manner, placing an emphasis on safe operations and ramping up supply of essential ingredients and materials to address the crisis, while some successfully pivoted into new product lines.

This article defines similar devices and best practices for similar device data included in state of the art evaluations and CERs under EU regulations.

Dramatic changes to the regulatory landscape for in vitro diagnostic (IVD) medical devices are in the making. Some of the most impactful changes include a new classification of IVDs, an expansion of post market surveillance and the increased need for Notified Body review. Most medical device manufacturers are aware that failure to meet In Vitro Diagnostic Regulation (IVDR) 2017/746 deadlines can result in either failure to obtain a CE marking or loss of a currently valid CE mark. The deadlines, however, are not written in stone.

Medical device literature reviews for EU CERs present a challenge to many manufacturers. The literature review component of your CER will undergo robust scrutiny by the Notified Bodies.